Please login to the form below

Not currently logged in
Email:
Password:

Brexit

This page shows the latest Brexit news and features for those working in and with pharma, biotech and healthcare.

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Away from the coronavirus measures, there was very little mention of Brexit, but plenty to digest for the biopharma industry in a budget that seems to mark a return to the

Latest news

  • It’s Brexit day – now comes the really hard stuff It’s Brexit day – now comes the really hard stuff

    Michael Warren, who covers Brexit and trade issues for the BIA, said that there’s been no change to the industry position on the negotiation phase for the trade deal. ... It’s worth noting that despite the disruption caused by the build-up to Brexit,

  • Boris Johnson to unveil ‘talent visa’ for high-flying scientists Boris Johnson to unveil ‘talent visa’ for high-flying scientists

    Last October, a  report suggested that the UK was experiencing a drop in research application grants for top scientific talent, which had been attributed to Brexit uncertainty.

  • UK biotech funding falls 40% between 2018 and 2019 UK biotech funding falls 40% between 2018 and 2019

    According to Dan Mahony, partner at Polar Capital, “investor appetite for small companies has evaporated given the uncertainty surrounding Brexit”, and “the well-publicised issues with the Woodford Funds have also

  • EU group calls for 'targeted actions' to mitigate impact of Brexit EU group calls for 'targeted actions' to mitigate impact of Brexit

    A European Parliament committee has called for 'targeted actions' to ensure the continuing supply of drugs and medical devices after Brexit. ... The system would enable people who enter the UK after Brexit to seek recognition for their qualifications.

  • The year in review The year in review

    For example, the continued uncertainty around Brexit and its impact on the life sciences community was a big story in 2019. ... With a new Brexit deadline of 31 January 2020, it is sure to be on the list next year.

More from news
Approximately 171 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • A snapshot of… Exscientia A snapshot of… Exscientia

    What impact is the planned Brexit having on the company? For Exscientia, access to great talent is vital.

  • Health trust in a COVID-19 world – a unique opportunity for pharma Health trust in a COVID-19 world – a unique opportunity for pharma

    A 13-point fall in the UK could have been a reaction to the Brexit debate at the time the survey was fielded, with media focus on underfunding and potential staff ... shortages given immigration restrictions post-Brexit.

  • A snapshot of… Enterprise Therapeutics A snapshot of… Enterprise Therapeutics

    companies. However, it remains to be seen what effects Brexit may have on future fundraising opportunities for the UK biotech industry. ... and partners and the impact Brexit may have on their businesses, rather than it having a direct effect internally.

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    The agency advertised for applications for the role last year. The new executive director will have the challenge of the continuing fallout affecting the EMA post-Brexit and its forced move

  • The roaring ‘20s and Generation Z The roaring ‘20s and Generation Z

    The NHS reform agenda. The other significant impact of the large majority is that the Government has taken back control of the Brexit agenda from Parliament, which means the domestic policy

More from intelligence
Approximately 19 fully matching, plus 46 partially matching documents found.

Latest from PMHub

  • HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE

    This trend is vitally important at a time when the region is considering its post Brexit economic future. ... In a post Brexit Britain where the UK’s future trading relationship with the EU remains uncertain, adopting more innovative business practices

  • How will the Tories’ historic win shape the NHS?

    Brexit. If Brexit does hit the supply chain, UK pharma companies with branded drugs could leverage an advantage over companies selling generics sourced from abroad. ... Conclusion. While questions remain unanswered on many key issues, particularly around

  • What are you doing, Dave?

    Hey Siri, find a solution to Brexit.He might be disappointed at the banal tasks to which most AI is being put: labour-saving digital assistants that allow people to turn

  • Pegasus expands Pharma team with senior hires

    Account Director, Ed Sexton, previously led media relations for the UK BioIndustry Association, whose award-winning Brexit campaign represented more than 330 life sciences companies in the UK.

  • GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT

    At the start of a year of expected political and economic uncertainty, Brexit is their biggest worry with two-thirds (59%) believing an exit from Europe will have a negative impact ... Regardless of Brexit, both groups seem concerned about the longevity

More from PMHub
Approximately 4 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics